AU2013200394B2 — Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
Assigned to Bayer Healthcare LLC · Expires 2015-07-09 · 11y expired
What this patent protects
Abstract A compound of Formula (I): (I) salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions to treat diseases mediated by raf, VEGFR, PDGFR, p38 and flt-3. C: \NRPortbl\DCC\TZM\488…
USPTO Abstract
Abstract A compound of Formula (I): (I) salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions to treat diseases mediated by raf, VEGFR, PDGFR, p38 and flt-3. C: \NRPortbl\DCC\TZM\4884362 I.DOC - 24/1/13
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.